anesthesia and tirzepatide Surgery/Anesthesia while taking GLP-1's New Study Recommends Stopping GLP-1

GLP-1 medications are especially valuable during menopause because they help manage the appetite changes that many women experience during this transition

cost and insurance coverage vary widely

Non-significant results were primarily observed for pancreatitis, severe hypoglycemia, and serious adverse events (SAEs)

Semaglutide, the active ingredient in Wegovy, follows a carefully structured dose escalation protocol that starts low and increases every four weeks

Type 2 diabetes specific considerations Individuals with type 2 diabetes starting tirzepatide often require adjustments to their existing diabetes medications